Skip to main content
Erschienen in: Reactions Weekly 1/2018

01.07.2018 | Case report

Erlotinib/gefitinib/vinorelbine

Development of resistance mutation and transformation of the adenocarcinoma to a squamous cell carcinoma (SCC): case report

Erschienen in: Reactions Weekly | Ausgabe 1/2018

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Haumaier F, et al. Histologic transformation of an adenocarcinoma to a squamous cell carcinoma after vinorelbine treatment. Pneumologie 72 (Suppl. 1): abstr. S39, 21 Feb 2018. Available from: URL: http://doi.org/10.1055/s-0037-1619219 [abstract] - Germany Haumaier F, et al. Histologic transformation of an adenocarcinoma to a squamous cell carcinoma after vinorelbine treatment. Pneumologie 72 (Suppl. 1): abstr. S39, 21 Feb 2018. Available from: URL: http://​doi.​org/​10.​1055/​s-0037-1619219 [abstract] - Germany
Metadaten
Titel
Erlotinib/gefitinib/vinorelbine
Development of resistance mutation and transformation of the adenocarcinoma to a squamous cell carcinoma (SCC): case report
Publikationsdatum
01.07.2018
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2018
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-018-49516-4

Weitere Artikel der Ausgabe 1/2018

Reactions Weekly 1/2018 Zur Ausgabe

Case report

Denosumab